Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 7 results for "cadila pharmaceutical"

OTC biz to contribute 15-20% to revenues

Ankit Bhembre & Karthikeyan Thangarajan(Analysts, Ind-Ra) We expect Indian formulators to continue to make investments to grow their domestic non-prescription business through organic and inorganic routes. It would be driven by the need to further diversify ... The Financial Chronicle, 2 days ago

4 images for cadila pharmaceutical

Business Standard, 4 months ago
Business Standard, 5 months ago
Money Control, 6 months ago
Money Control, 6 months ago

Global Stock Pare Losses After Robust US Jobs Data

Posted by Equitymaster Global financial markets slumped this week after the US imposed steel and aluminium tariffs on exports. However, markets worldwide pared the losses on Friday amid robust US jobs data. Data from the U.S. Labor Department revealed that ...
 Equitymaster.com1 month ago

Sensex Ends 318 Points Up; Realty & Banking Stocks Rally

Posted by Equitymaster Indian share markets ended higher today as Asian equities rose on hopes that US President Donald Trump's plan to introduce hefty tariffs on steel and aluminium imports could exclude certain key partner countries. At the closing bell, ...
 Equitymaster.com1 month ago
Rediff.com

Prices of key diabetes, cancer drugs may drop by 25%

A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments. The next three to five years would see some key cardiovascular, diabetic and oncology molecules going off-patent in the Indian market.   This could trigger launches of generic versions by local players and, thereby, a major drop in their prices. Experts expect the sharpest price drop in the oncology space.
 Rediff.com1 month ago
Rediff.com

Can these stocks shine amid market gloom?

Investors turn their attention to export-driven sectors, experts tell Krishna Kant. Illustration: Uttam Ghosh After betting on the domestic consumption story for over three years, equity investors could now turn their attention to export-driven sectors. In the last month, the S&P BSE Sensex is down six per cent, while the Nifty IT (information technology) index is down only 1.5 per cent during this period. Other export-focused companies in pharmaceutical, automobile and agrochemicals ...
 Rediff.com1 month ago

'India must create more jobs to become a global force'

India needs to create more jobs for youth by encouraging entrepreneurship to become a global economic force, a plenary panel session at the sixth World Government Summit here has concluded.The session debated whether this year's guest nation India could ever ...
 Business Standard2 months ago

Indian Indices Continue Momentum; Healthcare Stocks Witness Buying

Posted by Equitymaster After opening the day on a positive note, stock markets in India have continued their momentum and are presently trading in the green. Sectoral indices are trading on a positive note with stocks in the realty sector , healthcare sector ...
 Equitymaster.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less